PERITONEAL GLIOMATOSIS

This adverse event was reported 6 times

These drugs are most commonly taken by patients reporting PERITONEAL GLIOMATOSIS:

# Drug Count
0 CISPLATIN 5
1 ETOPOSIDE 5
2 BLEOMYCIN 4
3 BLEOMYCIN SULFATE 4
4 BEVACIZUMAB 1
5 IFOSFAMIDE 1
6 IFOSFAMIDE FOR INJECTION 1
7 TEMOZOLOMIDE 1
8 TRAMETINIB 1
See all common drugs associated with PERITONEAL GLIOMATOSIS

PERITONEAL GLIOMATOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BLEOMYCIN SULFATE 4 0.0004
1 ETOPOSIDE 5 0.0001
2 CISPLATIN 5 0.0001
3 TEMOZOLOMIDE 1 0.0000
4 IFOSFAMIDE FOR INJECTION 1 0.0000
5 TRAMETINIB 1 0.0000
6 BEVACIZUMAB 1 0.0000
See all drugs enriched for association with PERITONEAL GLIOMATOSIS

These drug classes are most commonly taken by patients reporting PERITONEAL GLIOMATOSIS:

# Drug class Count
0 Platinum-based Drug [EPC] 5
1 Topoisomerase Inhibitor [EPC] 5
2 Alkylating Drug [EPC] 2
3 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
See all common drug classes associated with PERITONEAL GLIOMATOSIS

PERITONEAL GLIOMATOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 5 0.0001
1 Platinum-based Drug [EPC] 5 0.0000
2 Alkylating Drug [EPC] 2 0.0000
3 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with PERITONEAL GLIOMATOSIS